UPDATE 2-U.S. appeals court upholds ruling invalidating J&J patent on Remicade
January 23, 2018 at 14:01 PM EST
Jan 23 (Reuters) - A U.S. appeals court on Tuesday upheld a ruling that invalidated a crucial Johnson & Johnson patent on its blockbuster rheumatoid arthritis drug Remicade, limiting J&J’s ability to seek damages from Pfizer Inc over its launch of a lower-cost version of the drug.